|
|
Article: MedManage Systems Receives $6 Million in Series C Funding; New Investors Versant Ventures and Lilly Ventures Underscore Potential of MedManage's Next-Generation Drug-Sampling Solution.
- Article from:
- PR Newswire
- Article date:
- April 26, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOTHELL, Wash., April 26 /PRNewswire/ -- MedManage Systems Inc., a leading provider of intelligent prescription drug-sampling solutions, today announced it has received $6 million in Series C Preferred funding. The new round of financing was led by Versant Ventures, a venture capital firm that invests in early-stage healthcare companies promising to be significant, long-term market leaders. Other investors joining the round include Lilly Ventures and existing investor, Prism Venture Partners.
"The addition of Versant and Lilly Ventures, two prestigious investors, reflects the great potential MedManage's innovative solutions bring to the pharmaceutical ...
Related newspaper, magazine, and journal articles:
|
|
Article: MedManage Systems Closes Additional $3.5 Million in ...
PR Newswire;
December 12, 2002 ;
700+ words
...BOTHELL, Wash. -- MedManage Systems, the leading provider of online prescription drug ... at http://www.prismventure.com/ . About MedManage Systems MedManage Systems is the leading provider of online drug sampling solutions ...
|
|